Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
The mission of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is to go beyond the cutting edge in science and medicine to perform […]
The mission of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is to go beyond the cutting edge in science and medicine to perform […]
Hoosier Cancer Research Network investigators presented a trials in progress poster featuring the HCRN study GU17-295 during the American Society of Clinical Oncology’s 2020 Genitourinary […]
This month, Hoosier Cancer Research Network highlights the work of University of Arizona Cancer Center at Dignity Health St. Joseph’s as a featured member of […]
This month, Hoosier Cancer Research Network features our member institution Froedtert & the Medical College of Wisconsin in Milwaukee, Wis., and Deepak Kilari, MD, a […]
A multi-institutional single-arm study led by Rachel Sanborn, MD, of the Earle A. Chiles Research Institute, a division of Providence Cancer Institute, is testing the […]
Investigators reported results from two HCRN studies during poster sessions at the 2019 World Conference on Lung Cancer, September 7-9 in Barcelona, Spain. Study authors, […]
Hoosier Cancer Research Network recently opened a cancer clinical trial for subjects with advanced colorectal cancer. The study, known as GI14-186, involves the study drug […]
Observational basket trial to predict response to immune checkpoint inhibitors across solid tumors using a live tumor diagnostic platform (CYBRID-02) Status: Open to Accrual
Hoosier Cancer Research Network (HCRN) recently marked its 30th anniversary with a dinner and presentation of awards. The event featured comments by HCRN co-founder Patrick […]
Hoosier Cancer Research Network co-founder Kenneth L. Pennington, MD, recently retired from the IU Health Goshen Center for Cancer Care after 34 years of practice […]
As Hoosier Cancer Research Network celebrates our 30th anniversary, we acknowledge another significant milestone: the 40th anniversary of the discovery of the cure for testicular […]
More than 30 years ago, a group of academic and community physicians in Indiana launched the Hoosier Oncology Group (or the “HOG”) as a new […]
Randomized phase 2 trial of gemcitabine + carboplatin + nivolumab versus gemcitabine + oxaliplatin + nivolumab in cisplatin-ineligible patients with metastatic urothelial cancer Status: Closed to […]
A Single Arm Phase II Study with Safety Run-in of Peptide Receptor Radionuclide Therapy (PRRT) in Combination with Immunotherapy for Patients with Merkel Cell Cancer […]
In an oral abstract session at the 2016 Genitourinary Cancers Symposium, Matthew Galsky, MD, reported on the HCRN GU10-148 study, a phase II trial of […]
Hoosier Cancer Research Network, formerly known as Hoosier Oncology Group, recently honored Donald C. “Danny” Danielson with the 2013 Terry Hoeppner Patient Advocacy Award in […]
Hoosier Cancer Research Network (HCRN) recently launched a cancer clinical trial evaluating the efficacy of the PDL-1 inhibiting drug pembrolizumab in the treatment of patients […]
In 1984, a small group of community-based oncologists and faculty members at the Indiana University Cancer Center came together with a shared mission: bring academic […]
Three Hoosier Cancer Research Network studies were featured in poster sessions during the 2017 Gastrointestinal Cancers Symposium, Feb. 16-18 in Orlando.
Researchers investigating many types of cancers have celebrated significant breakthroughs over the years. Yet, some cancers lag well behind these successes. Pancreatic cancer remains one […]
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter